High level expression of His-tagged colicin 5 in E. coli and characterization of its narrow-spectrum bactericidal activity and pore-forming action

Protein Expression and Purification

Volumn 54, Issue 2, 2007, Pages 309-317

  Yang, Hao ^a   Wan, Lin ^a   Li, Xiaowei ^a   Cai, Huawei ^a   Chen, Lihong ^a   Li, Shengfu ^a   Li, Youping ^a   Cheng, Jingqiu ^a   Lu, Xiaofeng ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Antibiotics; Bacteriocin; Channel forming protein; Colicin; Microcin

Indexed keywords

BACTERIAL PROTEIN; COLICIN; COLICIN 5 PROTEIN, E COLI; COLICIN IMMUNITY PROTEINS; ESCHERICHIA COLI PROTEIN; HISTIDINE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL MEMBRANE PERMEABILITY; CHEMISTRY; DRUG EFFECT; ESCHERICHIA COLI; GENETICS; HEMOLYSIS; METABOLISM; MICROBIOLOGICAL EXAMINATION; MOLECULAR CLONING; RABBIT;

ANIMALS; BACTERIAL PROTEINS; CELL MEMBRANE PERMEABILITY; CLONING, MOLECULAR; COLICINS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HEMOLYSIS; HISTIDINE; MICROBIAL SENSITIVITY TESTS; RABBITS;

ANIMALIA; ESCHERICHIA COLI; MAMMALIA; NEGIBACTERIA; ORYCTOLAGUS CUNICULUS; POSIBACTERIA;

EID: 34249019199     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2007.03.006     Document Type: Article

References (34)

1. Daw M.A., and Falkiner F.R. Bacteriocins: nature, function and structure. Micron 27 (1996) 467-479
2. O'Sullivan L., Ross R.P., and Hill C. Potential of bacteriocin-producing lactic acid bacteria for improvements in food safety and quality. Biochimie 84 (2002) 593-604
3. Cotter P.D., Hill C., and Ross R.P. Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 3 (2005) 777-788
4. Finch R.G. Antibiotic resistance: a view from the prescriber. Nat. Rev. Microbiol. 2 (2004) 989-994
5. Gillis L.M., White H.D., Whitehurst A., and Sullivan D.C. Vancomycin -tolerance among clinical isolates of Streptococcus pneumoniae in Mississippi during 1999-2001. Am. J. Med. Sci. 330 (2005) 65-68
6. Reinert R.R., Reinert S., van der Linden M., Cil M.Y., Al-Lahham A., and Appelbaum P. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob. Agent. Chem. 49 (2005) 2903-2913
7. Furuya E.Y., and Lowy F.D. Antimicrobial-resistant bacteria in the community setting. Nat. Rev. Microbiol. 4 (2006) 36-45
8. Cook D.N., Pisetsky D.S., and Schwartz D.A. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5 (2004) 975-979
9. Ulevitch R.J., Mathison J.C., and Correia J.S. Innate immune responses during infection. Vaccine 22S (2004) S25-S30
10. Gillor O., Kirkup B.C., and Riley M.A. Colicins and microcins: the next generation antimicrobials. Adv. Appl. Microbiol. 54 (2004) 129-146
11. Gillor O., Nigro L.M., and Riley M.A. Genetically engineered bacteriocins and their potential as the next generation of antimicrobials. Curr. Pharm. Des. 11 (2005) 1067-1075
12. Cohen J. Recent developments in the identification of novel therapeutic targets for the treatment of patients with sepsis and septic shock. Scand J. Infect. Dis. 35 (2003) 690-696
13. Walsh C. Where will new antibiotics come from?. Nat. Rev. Microbiol. 1 (2003) 65-70
14. Michel-Briand Y., and Baysse C. The pyocins of Pseudomonas aeruginosa. Biochimie 84 (2002) 499-510
15. Rodriguez J.M., Martinez M.I., Horn N., and Dodd H.M. Heterologous production of bacteriocins by lactic acid bacteria. Int. J. Food Microbiol. 80 (2003) 101-116
16. Braun V., Pilsl H., and Gross P. Colicins: structures, modes of action, transfer through membranes, and evolution. Arch. Microbiol. 161 (1994) 199-206
17. Qiu X.Q., Wang H., Lu X.F., Zhang J., Li S.F., Cheng G., Wan L., Yang L., et al. An engineered multidomain bactericidal peptide as a model for targeted antibiotics against for specific bacteria. Nat. Biotechnol. 21 (2003) 1480-1485
18. Qiu X.Q., Zhang J., Wang H., and Wu G. A novel engineered peptide, a narrow-spectrum antibiotic is effective against vancomycin-resistant Enterococcus faecalis. Antimicrob. Agent. Chem. 49 (2005) 1184-1189
19. Cramer W.A., Heymann J.B., Schendel S.L., Deriy B.N., Cohen F.S., Elkins P.A., and Stauffacher C.V. Structure-function of the channel-forming colicins. Annu. Rev. Biophys. Biomol. Struct. 24 (1995) 611-641
20. Wertz J.E., and Riley M.A. Chimeric nature of two plasmids of Hafnia alvei encoding the bacteriocins alveicins A and B. J. Bacteriol. 186 (2004) 1598-1605
21. Pilsl H., and Braun V. Evidence that the immunity protein inactivates colicin 5 immediately prior to the formation of the transmembrane channel. J. Bacteriol. 177 (1995) 6966-6972
22. Pilsl H., and Braun V. Strong function-related homology between the pore-forming colicins K and 5. J. Bacteriol. 177 (1995) 6973-6977
23. Zeiger A.R., Wong W., Chatterjee A.N., Young F.E., and Tuazon C.U. Evidence for the secretion of soluble peptidoglycans by clinical isolates of Staphylococcus aureus. Infect. Immun. 37 (1982) 1112-1118
24. Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
25. Lu X., Wang M., Qi J., Wang H., Li X., Gupta D., and Dziarski R. Peptidoglycan recognition proteins are a new class of human bactericidal proteins. J. Biol. Chem. 281 (2006) 5895-5907
26. Nekhotiaeva N., Elmquist A., Rajarao G.K., Hallbrink M., Langel U., and Good L. Cell entry and antimicrobial properties of eukaryotic cell-penetrating peptides. FASEB J. 18 (2004) 394-396
27. Fridd S.L., Gokce I., and Lakey J.H. High level expression of His-tagged colicin pore-forming domains and reflections on the sites for pore formation in the inner membrane. Biochimie 84 (2002) 477-483
28. Geli V., Baty D., Crozel V., Morlon J., Lloubes R., Pattus F., and Lazdunski C. A molecular genetic approach to the functioning of the immunity protein to colicin A. Mol. Gen. Genet. 202 (1986) 455-460
29. Zhang L.H., Fath M.J., Mahanty H.K., Tai P.C., and Kolter R. Genetic analysis of the colicin V secretion pathway. Genetics 141 (1995) 25-32
30. Anthony L.C., Suzuki H., and Filutowicz M. Tightly regulated vectors for the cloning and expression of toxic genes. J. Microbiol. Methods 58 (2004) 243-250
31. Lazdunski C.J., Bouveret E., Rigal A., Journet L., Lloubes R., and Benedetti H. Colicin import into Escherichia coli cells. J. Bacteriol. 180 (1998) 4993-5002
32. Brogden K.M. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 3 (2005) 238-250
33. Zakharov S.D., Kotovac E.A., Antonenkoc Y.N., and Cramera W.A. On the role of lipid in colicin pore formation. Biochimica. et. Biophysica. Acta. 1666 (2004) 239-249
34. Chumchalova J., and Smarda J. Human tumor cells are selectively inhibited by colicins. Folia Microbiol. (Praha) 48 (2003) 111-115